Abstract
Merkel cell carcinoma (MCC) is a rare type of skin cancer. It is the first human cancer known to be associated with a polyomavirus. The vast majority of publications are case reports. Our goal is to discuss practical suggestions for the treatment, based on our clinical experience and a review of the literature. Surgery is the initial treatment of choice. Radiotherapy is used as primary or adjuvant treatment. The chemotherapeutic approach follows that of neuroendocrine neoplasms, using cisplatin and etoposide. Researchers are looking into other active drugs which have been used for melanoma including temozolomide, and PD-1 inhibitors. Scientists are studying mutations in MCC to identify potential targets for more effective systemic treatments. We hope this review will be useful for clinicians to apply current principles and provide food for thought to improve treatment outcomes.
Keywords: Chemotherapy, polyomavirus, radiotherapy, surgery.
Graphical Abstract
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Current Drug Metabolism
Related Books
Anthocyanins: Pharmacology and Nutraceutical Importance
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings
Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention
Drug Addiction Mechanisms in the Brain
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Frontiers in Clinical Drug Research - Anti-Cancer Agents
The Management of Metastatic Triple-Negative Breast Cancer: An Integrated and Expeditionary Approach
Advanced Pharmacy
14